Clinical trialNCT03487913CompletedPhase 2Interventional

The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

SponsorPalladio BiosciencesEnrollment31Autosomal Dominant Polycystic Kidney Disease

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Vicente E Torres, MD, PhD
Mayo Clinic
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Palladio Biosciences Clinical Site
Los Angeles, California, United States
Palladio Biosciences Clinical Site
Jacksonville, Florida, United States
Palladio Biosciences Clinical Site
Miami, Florida, United States
Palladio Biosciences Clinical Site
Miami, Florida, United States
Palladio Biosciences Clinical Site
Palmetto Bay, Florida, United States
Palladio Biosciences Clinical Site
Tampa, Florida, United States
Palladio Biosciences Clinical Site
Baltimore, Maryland, United States
Palladio Biosciences Clinical Site
Rochester, Minnesota, United States
Palladio Biosciences Clinical Site
Kansas City, Missouri, United States
Palladio Biosciences Clinical Site
Laurelton, New York, United States
Palladio Biosciences Clinical Site
Indiana, Pennsylvania, United States
Palladio Biosciences Clinical Site
Nashville, Tennessee, United States
Palladio Biosciences Clinical Site
Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 14 Sept 2018
Primary completion: 2 Dec 2019
Completion: 11 Feb 2020
Last update posted: 5 Dec 2022
Registered enrollment: 31
Registry id: NCT03487913

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.